CareDx, Inc. CDNA
Updated: 18 Jun 2026
No signal published yet
We already track CareDx and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow CareDx, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow CareDx free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
In June 2026, CareDx announced a strategic agreement to acquire Naveris for up to $260 million to expand its presence in the precision oncology market. This follows the company's April 2026 announcement to divest its Lab Products business to Eurobio Scientific for $170 million. The company also reported strong Q1 2026 financial results with 39% year-over-year revenue growth.
What Firelda Watch includes for CareDx, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow CareDx, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow CareDx free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more